Regenerative pulmonary medicine: Potential and promise, pitfalls and challenges

Piero Anversa, Mark A. Perrella, Stella Kourembanas, Augustine M.K. Choi, Joseph Loscalzo

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Background Chronic lung diseases contribute significantly to the morbidity and mortality of the population. There are few effective treatments for many chronic lung diseases, and even fewer therapies that can arrest or reverse the progress of the disease. Design In this review, we present the current state of regenerative therapies for the treatment of chronic lung diseases. We focus on endothelial progenitor cells, mesenchymal stem cells, and endogenous lung stem/progenitor cells; summarize the work to date in models of lung diseases for each of these therapies; and consider their potential benefits and risks as viable therapies for patients with lung diseases. Conclusions Cell-based regenerative therapies for lung diseases offer great promise, with preclinical studies suggesting that the next decade should provide the evidence necessary for their ultimate application to our therapeutic armamentarium.

Original languageEnglish (US)
Pages (from-to)900-913
Number of pages14
JournalEuropean Journal of Clinical Investigation
Issue number8
StatePublished - Aug 2012


  • Emphysema
  • Lung injury
  • Mesenchymal stem cell
  • Pulmonary hypertension
  • Regenerative medicine
  • Stem cell

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry


Dive into the research topics of 'Regenerative pulmonary medicine: Potential and promise, pitfalls and challenges'. Together they form a unique fingerprint.

Cite this